The question they "should" have asked was did the alleged seller in fact buy stock following the removal of the "authentic" sell order.
ACW This biotech stock raised $11M in a risk-off environment. Its Alzheimer's drug could change the game
History-making uranium sample grades and an imminent drill run. Infini Resources is poised to transform in 2025